Related Experiment Video
Updated: Dec 13, 2025

09:26
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
Published on: January 22, 2014
15.8K
Microarray profiling and functional analysis of differentially expressed plasma exosomal circular RNAs in Graves'
Ying Sun1, Wei Wang1, Yuxiao Tang1
1Department of Endocrinology, Affiliated Yantai Yuhuangding Hospital of Qingdao University Medical College, Yantai, Shandong, China.
Biological Research
|July 31, 2020
Summary
Graves' disease (GD) involves altered exosomal circular RNAs (circRNAs). Researchers identified hsa_circRNA_000102 as elevated in GD patients, suggesting roles in immune activation pathways like viral infection.
Area of Science:
- Endocrinology
- Molecular Biology
- Immunology
Background:
- Circulating RNAs (circRNAs) play roles in cellular functions.
- Exosomal circRNAs offer insights into Graves' disease (GD) pathogenesis and treatment.
- Understanding circRNA profiles in GD can reveal disease mechanisms.
Purpose of the Study:
- To profile differentially expressed circRNAs (DEcRs) in plasma exosomes of GD patients.
- To investigate the functions of identified DEcRs using bioinformatics analyses.
- To explore potential therapeutic targets for Graves' disease.
Main Methods:
- Exosomes were isolated from GD patients and healthy controls using ultracentrifugation.
- circRNA microarrays were used for profiling, followed by RT-qPCR validation.
- circRNA/microRNA/mRNA networks and pathway analyses (GO, KEGG) were performed.
Main Results:
- Fifteen DEcRs were identified in GD patients.
- hsa_circRNA_000102 was confirmed as significantly up-regulated in plasma exosomes of GD patients.
- Functional analysis predicted involvement in immune activation pathways, including viral infection and interferon-beta signaling.
Conclusions:
- hsa_circRNA_000102 is a key up-regulated exosomal circRNA in Graves' disease.
- This circRNA and its associated genes are implicated in immune system activation pathways.
- The findings highlight potential mechanisms of immune dysregulation in GD.

